[HTML][HTML] Oxidative stress in age-related neurodegenerative diseases: An overview of recent tools and findings
D Korovesis, T Rubio-Tomás, N Tavernarakis - Antioxidants, 2023 - mdpi.com
Reactive oxygen species (ROS) have been described to induce a broad range of redox-
dependent signaling reactions in physiological conditions. Nevertheless, an excessive …
dependent signaling reactions in physiological conditions. Nevertheless, an excessive …
[HTML][HTML] A triterpenoid lupeol as an antioxidant and anti-neuroinflammatory agent: impacts on oxidative stress in Alzheimer's disease
Alzheimer's disease (AD) is the most common neurodegenerative disease illustrated by
neuronal dysfunctions, leading to memory weaknesses and personality changes mostly in …
neuronal dysfunctions, leading to memory weaknesses and personality changes mostly in …
[HTML][HTML] Oxidative stress as a potential mechanism underlying membrane hyperexcitability in neurodegenerative diseases
R Pardillo-Díaz, P Pérez-García, C Castro… - Antioxidants, 2022 - mdpi.com
Neurodegenerative diseases are characterized by gradually progressive, selective loss of
anatomically or physiologically related neuronal systems that produce brain damage from …
anatomically or physiologically related neuronal systems that produce brain damage from …
[HTML][HTML] Cryo-EM structures of lipidic fibrils of amyloid-β (1-40)
B Frieg, M Han, K Giller, C Dienemann… - Nature …, 2024 - nature.com
Alzheimer's disease (AD) is a progressive and incurable neurodegenerative disease
characterized by the extracellular deposition of amyloid plaques. Investigation into the …
characterized by the extracellular deposition of amyloid plaques. Investigation into the …
[HTML][HTML] The molecular effects of environmental enrichment on Alzheimer's disease
Environmental enrichment (EE) is an environmental paradigm encompassing sensory,
cognitive, and physical stimulation at a heightened level. Previous studies have reported the …
cognitive, and physical stimulation at a heightened level. Previous studies have reported the …
[HTML][HTML] Role of SUMOylation in neurodegenerative diseases
N Mandel, N Agarwal - Cells, 2022 - mdpi.com
Neurodegenerative diseases (NDDs) are irreversible, progressive diseases with no effective
treatment. The hallmark of NDDs is the aggregation of misfolded, modified proteins, which …
treatment. The hallmark of NDDs is the aggregation of misfolded, modified proteins, which …
Alpinetin inhibits neuroinflammation and neuronal apoptosis via targeting the JAK2/STAT3 signaling pathway in spinal cord injury
S Xiao, Y Zhang, Z Liu, A Li, W Tong… - CNS neuroscience & …, 2023 - Wiley Online Library
Background A growing body of research shows that drug monomers from traditional
Chinese herbal medicines have antineuroinflammatory and neuroprotective effects that can …
Chinese herbal medicines have antineuroinflammatory and neuroprotective effects that can …
[HTML][HTML] Neuromodulatory effect of vardenafil on aluminium chloride/d-galactose induced Alzheimer's disease in rats: emphasis on amyloid-beta, p-tau, PI3K/Akt/p53 …
HH Awad, MA Desouky, A Zidan, M Bassem… - …, 2023 - Springer
Dysregulation of protein homeostasis, proteostasis, is a distinctive hallmark of many
neurodegenerative disorders and aging. Deleteriously, the accumulation of aberrant …
neurodegenerative disorders and aging. Deleteriously, the accumulation of aberrant …
[HTML][HTML] Liposome-derived nanosystems for the treatment of behavioral and neurodegenerative diseases: the promise of niosomes, transfersomes, and ethosomes for …
PC Pires, AC Paiva-Santos, F Veiga - Pharmaceuticals, 2023 - mdpi.com
Psychiatric and neurodegenerative disorders are amongst the most prevalent and
debilitating diseases, but current treatments either have low success rates, greatly due to the …
debilitating diseases, but current treatments either have low success rates, greatly due to the …
[HTML][HTML] Photobiomodulation in Alzheimer's disease—A complementary method to state-of-the-art pharmaceutical formulations and nanomedicine?
Alzheimer's disease (AD), as a neurodegenerative disorder, usually develops slowly but
gradually worsens. It accounts for approximately 70% of dementia cases worldwide, and is …
gradually worsens. It accounts for approximately 70% of dementia cases worldwide, and is …